PURPOSE: Single-nucleotide polymorphisms (SNPs) in AT-rich interactive domain 5B (ARID5B) have been associated with risk for pediatric acute lymphoblastic leukemia (ALL). After reviewing previous studies, we realized that the most significant associations were restricted to intron 3, but the mechanism(s) by which those SNPs affect ALL risk remain to be elucidated. Therefore, the aim of this study was to analyze the association between genetic variants of the intron 3 region of ARID5B and the incidence of B-ALL in a Spanish population. We also aimed to find a functional explanation for the association, searching for copy number variations (CNVs), and changes in ARID5B expression associated with the genotypes of the SNPs. METHODS: We analyzed 10 SNPs in intron 3 of ARID5B in a Spanish population of 219 B-ALL patients and 397 unrelated controls with the Taqman Open Array platform. CNVs were analyzed in 23 patients and 17 controls using the Cytogenetics Whole-genome 2.7 M platform. Expression of ARID5B transcript 1 was quantified by qPCR and related to SNPs genotype in seven ALL cell lines. RESULTS: Association between intron 3 and B-ALL risk was confirmed for all of the SNPs evaluated in our Spanish population. We could not explain this association by the presence of CNVs. We neither detected changes in the expression of ARID5B isoform associated with the genotype of the SNPs. CONCLUSIONS: The intron 3 of ARID5B gene was found to be strongly associated with B-ALL risk in the Spanish population examined. However, neither CNVs nor changes in mRNA expression were found to be responsible for this association.
PURPOSE: Single-nucleotide polymorphisms (SNPs) in AT-rich interactive domain 5B (ARID5B) have been associated with risk for pediatric acute lymphoblastic leukemia (ALL). After reviewing previous studies, we realized that the most significant associations were restricted to intron 3, but the mechanism(s) by which those SNPs affect ALL risk remain to be elucidated. Therefore, the aim of this study was to analyze the association between genetic variants of the intron 3 region of ARID5B and the incidence of B-ALL in a Spanish population. We also aimed to find a functional explanation for the association, searching for copy number variations (CNVs), and changes in ARID5B expression associated with the genotypes of the SNPs. METHODS: We analyzed 10 SNPs in intron 3 of ARID5B in a Spanish population of 219 B-ALL patients and 397 unrelated controls with the Taqman Open Array platform. CNVs were analyzed in 23 patients and 17 controls using the Cytogenetics Whole-genome 2.7 M platform. Expression of ARID5B transcript 1 was quantified by qPCR and related to SNPs genotype in seven ALL cell lines. RESULTS: Association between intron 3 and B-ALL risk was confirmed for all of the SNPs evaluated in our Spanish population. We could not explain this association by the presence of CNVs. We neither detected changes in the expression of ARID5B isoform associated with the genotype of the SNPs. CONCLUSIONS: The intron 3 of ARID5B gene was found to be strongly associated with B-ALL risk in the Spanish population examined. However, neither CNVs nor changes in mRNA expression were found to be responsible for this association.
Authors: L Orsi; J Rudant; A Bonaventure; S Goujon-Bellec; E Corda; T-J Evans; A Petit; Y Bertrand; B Nelken; A Robert; G Michel; N Sirvent; P Chastagner; S Ducassou; X Rialland; D Hémon; E Milne; R J Scott; A Baruchel; J Clavel Journal: Leukemia Date: 2012-06-04 Impact factor: 11.528
Authors: Y Klipper-Aurbach; M Wasserman; N Braunspiegel-Weintrob; D Borstein; S Peleg; S Assa; M Karp; Y Benjamini; Y Hochberg; Z Laron Journal: Med Hypotheses Date: 1995-11 Impact factor: 1.538
Authors: Heng Xu; Cheng Cheng; Meenakshi Devidas; Deqing Pei; Yiping Fan; Wenjian Yang; Geoff Neale; Paul Scheet; Esteban G Burchard; Dara G Torgerson; Celeste Eng; Michael Dean; Frederico Antillon; Naomi J Winick; Paul L Martin; Cheryl L Willman; Bruce M Camitta; Gregory H Reaman; William L Carroll; Mignon Loh; William E Evans; Ching-Hon Pui; Stephen P Hunger; Mary V Relling; Jun J Yang Journal: J Clin Oncol Date: 2012-01-30 Impact factor: 44.544
Authors: M H Lahoud; S Ristevski; D J Venter; L S Jermiin; I Bertoncello; S Zavarsek; S Hasthorpe; J Drago; D de Kretser; P J Hertzog; I Kola Journal: Genome Res Date: 2001-08 Impact factor: 9.043
Authors: Johanna Samuelsson; Sergio Alonso; Tatiana Ruiz-Larroya; Tak Hong Cheung; Yick Fu Wong; Manuel Perucho Journal: Int J Oncol Date: 2011-03-11 Impact factor: 5.650
Authors: Orsolya Lautner-Csorba; András Gézsi; Agnes F Semsei; Péter Antal; Dániel J Erdélyi; Géza Schermann; Nóra Kutszegi; Katalin Csordás; Márta Hegyi; Gábor Kovács; András Falus; Csaba Szalai Journal: BMC Med Genomics Date: 2012-09-28 Impact factor: 3.063
Authors: E Ellinghaus; M Stanulla; G Richter; D Ellinghaus; G te Kronnie; G Cario; G Cazzaniga; M Horstmann; R Panzer Grümayer; H Cavé; J Trka; O Cinek; A Teigler-Schlegel; A ElSharawy; R Häsler; A Nebel; B Meissner; T Bartram; F Lescai; C Franceschi; M Giordan; P Nürnberg; B Heinzow; M Zimmermann; S Schreiber; M Schrappe; A Franke Journal: Leukemia Date: 2011-11-11 Impact factor: 11.528
Authors: Elli Papaemmanuil; Fay J Hosking; Jayaram Vijayakrishnan; Amy Price; Bianca Olver; Eammon Sheridan; Sally E Kinsey; Tracy Lightfoot; Eve Roman; Julie A E Irving; James M Allan; Ian P Tomlinson; Malcolm Taylor; Mel Greaves; Richard S Houlston Journal: Nat Genet Date: 2009-08-16 Impact factor: 38.330
Authors: Natalie P Archer; Virginia Perez-Andreu; Ulrik Stoltze; Michael E Scheurer; Anna V Wilkinson; Ting-Nien Lin; Maoxiang Qian; Charnise Goodings; Michael D Swartz; Nalini Ranjit; Karen R Rabin; Erin C Peckham-Gregory; Sharon E Plon; Pedro A de Alarcon; Ryan C Zabriskie; Federico Antillon-Klussmann; Cesar R Najera; Jun J Yang; Philip J Lupo Journal: PLoS One Date: 2017-08-17 Impact factor: 3.240
Authors: Wei Zhong Leong; Shi Hao Tan; Phuong Cao Thi Ngoc; Stella Amanda; Alice Wei Yee Yam; Wei-Siang Liau; Zhiyuan Gong; Lee N Lawton; Daniel G Tenen; Takaomi Sanda Journal: Genes Dev Date: 2018-01-11 Impact factor: 11.361
Authors: Angela Gutierrez-Camino; Idoia Martin-Guerrero; Vita Dolzan; Janez Jazbec; Ana Carbone-Bañeres; Nagore Garcia de Andoin; Ana Sastre; Itziar Astigarraga; Aurora Navajas; Africa Garcia-Orad Journal: Oncotarget Date: 2018-05-01